Ku80 as a novel receptor for thymosin β4 that mediates its intracellular activity different from G-actin sequestering

Ku80 as a novel receptor for thymosin β4 that mediates its intracellular activity different from G-actin sequestering
复制标题

DOI:
10.1074/jbc.m707539200
复制
发表时间:
2008-01-18
影响因子:
4.8
通讯作者:
Cierniewski, Czeslaw S.
Cierniewski, Czeslaw S.
中科院分区:
生物学2区
文献类型:
--
作者:
Bednarek, Radoslaw;Boncela, Joanna;Cierniewski, Czeslaw S.

文献摘要

被引文献

相似文献

我们的数据表明,胸腺素β 4 (T β 4)的细胞内表达增加是诱导内皮细胞纤溶酶原激活物抑制剂1型(PAI-1)基因表达的必要和充分条件。为了描述这种作用的机制,我们制造了功能基序受损的T β 4突变体,并测试了它们在细胞内的位置和活性。与绿色荧光蛋白融合的T β 4((AcSDKPT/4A))、T β 4((KLKKTET/7A))和T β 4((K16A))突变体的细胞质分布与野生型T β 4没有显著差异。T β 4、T β 4((AcSDKPT/4A))和T β 4((K16A))的过表达影响肌动蛋白丝的细胞内形成。正如预期的那样,细胞核对T β 4(K16A)的摄取受损。另一方面,T β 4((KLKKTET/7A))的过表达导致形成典型黏附细胞的肌动蛋白丝网络,表明突变体缺乏肌动蛋白结合位点。细胞内T β 4诱导PAI-1基因的机制不依赖于n端四肽AcSDKP,仅部分依赖于其结合g -肌动蛋白或进入细胞核的能力。T β 4和T β 4((AcSDKPT/4A))对PAI-1基因的诱导程度相同,而突变体T β 4((KLKKTET/7A))和T β 4((K16A))保留了约60%的原始活性。通过蛋白质组学分析,发现atp依赖性DNA解旋酶II的Ku80亚基与T β 4相关。Ku80和T β 4一致地在内皮细胞的复合物中共同免疫沉淀。内皮细胞与Ku80缺失突变体和T β 4共转染表明,Ku80的c端臂结构域直接参与这种相互作用。此外,特异性短干扰RNA下调Ku80可导致PAI-1在mRNA和蛋白合成水平上的表达显著降低。这些数据表明Ku80作为T β 4的新受体并介导其细胞内活性。
Our data demonstrate that increased intracellular expression of thymosin beta 4 (T beta 4) is necessary and sufficient to induce plasminogen activator inhibitor type 1 (PAI-1) gene expression in endothelial cells. To describe the mechanism of this effect, we produced T beta 4 mutants with impaired functional motifs and tested their intracellular location and activity. Cytoplasmic distributions of T beta 4((AcSDKPT/4A)), T beta 4((KLKKTET/7A)), and T beta 4((K16A)) mutants fused with green fluorescent protein did not differ significantly from those of wild-type T beta 4. Overexpression of T beta 4, T beta 4((AcSDKPT/4A)), and T beta 4((K16A)) affected intracellular formation of actin filaments. As expected, T beta 4((K16A)) uptake by nuclei was impaired. On the other hand, overexpression of T beta 4((KLKKTET/7A)) resulted in developing the actin filament network typical of adhering cells, indicating that the mutant lacked the actin binding site. The mechanism by which intracellular T beta 4 induced the PAI-1 gene did not depend upon the N-terminal tetrapeptide AcSDKP and depended only partially on its ability to bind G-actin or enter the nucleus. Both T beta 4 and T beta 4((AcSDKPT/4A)) induced the PAI-1 gene to the same extent, whereas mutants T beta 4((KLKKTET/7A)) and T beta 4((K16A)) retained about 60% of the original activity. By proteomic analysis, the Ku80 subunit of ATP-dependent DNA helicase II was found to be associated with T beta 4. Ku80 and T beta 4 consistently co-immunoprecipitated in a complex from endothelial cells. Co-transfection of endothelial cells with the Ku80 deletion mutants and T beta 4 showed that the C-terminal arm domain of Ku80 is directly involved in this interaction. Furthermore, down-regulation of Ku80 by specific short interference RNA resulted in dramatic reduction in PAI-1 expression at the level of both mRNA and protein synthesis. These data suggest that Ku80 functions as a novel receptor for T beta 4 and mediates its intracellular activity.